Sanofi (ADR) (NYSE:SNY)
CAPS Rating:
A global pharmaceutical group engaged in the research, development, manufacture and marketing of healthcare products.
The Official Website of the Long-Term Investor
A global pharmaceutical group engaged in the research, development, manufacture and marketing of healthcare products.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
SNY is a good investment because it does not depend on reviews of brokers and experts such as Zacks. Take for example NKBP: Zacks gives it as "strong buy" for the past nine months, in fact NKBP continues to fall